Dopamine pharmacokinetics in extremely premature infants: a pilot study - Dopamine pharmacokinetics
Phase 1
- Conditions
- eonatal hypotension
- Registration Number
- EUCTR2006-000832-28-GB
- Lead Sponsor
- iverpool Women's NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Infants born at less than 28 weeks gestation who require dopamine to treat systemic hypotension.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years)
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusion criteria are:
1) Known structural cardiac defects
2) Structural cardiac defects that become apparent during the study (not Patent foramen ovale)
3) Absence of arterial access as BP is not measured reliably in these infants.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method